Filing Flows › Companies › Surgery Partners › Timeline
Surgery Partners stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+7.3% to $23.20
Surgery Partners (SGRY) stock rose 7% over the last 252 sessions, to $23.20. On the way it reported 4 quarters, its insiders filed 12 open-market trades, and the company filed 5 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Oct 26, 2026 | 8-K | Material definitive agreement | +39.0% (+38.2% vs SPY) | +38.8% (+39.3% vs SPY) | — |
| Sep 17, 2026 | 8-K | Completed acquisition or disposition | −4.2% (−5.4% vs SPY) | +4.4% (+2.4% vs SPY) | +5.9% (+3.3% vs SPY) |
| Aug 18, 2026 | Insider buy | DeLuca Teresa bought $144K | −0.8% (−0.2% vs SPY) | −2.9% (−1.7% vs SPY) | −3.0% (−0.6% vs SPY) |
| Aug 10, 2026 | Earnings | Earnings: beat the EPS estimate by 59.6% | +2.7% (+2.7% vs SPY) | −3.3% (−3.7% vs SPY) | −10.7% (−9.7% vs SPY) |
| Jul 24, 2026 | 8-K | Material definitive agreement | +3.3% (+3.2% vs SPY) | +4.4% (+3.9% vs SPY) | −4.7% (−8.4% vs SPY) |
| May 5, 2026 | Earnings | Earnings: beat the EPS estimate by 77.8% | +0.4% (−0.4% vs SPY) | −3.0% (−5.9% vs SPY) | −5.0% (−9.9% vs SPY) |
| Mar 16, 2026 | Insider sale | Evans Jason Eric sold $254K | +0.1% (−0.9% vs SPY) | −4.8% (−3.0% vs SPY) | +5.7% (+0.6% vs SPY) |
| Mar 16, 2026 | Insider sale | Doherty David T sold $111K | +0.1% (−0.9% vs SPY) | −4.8% (−3.0% vs SPY) | +5.7% (+0.6% vs SPY) |
| Mar 13, 2026 | Insider sale | Burkhalter Danielle sold $45K | −2.9% (−2.3% vs SPY) | −5.6% (−4.6% vs SPY) | +2.7% (−0.5% vs SPY) |
| Mar 13, 2026 | Insider sale | Brittenham Marissa sold $46K | −2.9% (−2.3% vs SPY) | −5.6% (−4.6% vs SPY) | +2.7% (−0.5% vs SPY) |
| Mar 12, 2026 | Insider sale | Baldock Jennifer sold $76K | −5.6% (−4.1% vs SPY) | −8.7% (−6.4% vs SPY) | −4.3% (−5.1% vs SPY) |
| Mar 6, 2026 | Insider sale | Evans Jason Eric sold $158K | −5.5% (−4.1% vs SPY) | −10.2% (−8.0% vs SPY) | −13.7% (−10.7% vs SPY) |
| Mar 6, 2026 | Insider sale | Doherty David T sold $202K | −5.5% (−4.1% vs SPY) | −10.2% (−8.0% vs SPY) | −13.7% (−10.7% vs SPY) |
| Mar 6, 2026 | Insider sale | Burkhalter Danielle sold $105K | −5.5% (−4.1% vs SPY) | −10.2% (−8.0% vs SPY) | −13.7% (−10.7% vs SPY) |
| Mar 6, 2026 | Insider sale | Brittenham Marissa sold $120K | −5.5% (−4.1% vs SPY) | −10.2% (−8.0% vs SPY) | −13.7% (−10.7% vs SPY) |
| Mar 6, 2026 | Insider sale | Baldock Jennifer sold $138K | −5.5% (−4.1% vs SPY) | −10.2% (−8.0% vs SPY) | −13.7% (−10.7% vs SPY) |
| Mar 5, 2026 | Insider sale | Webb William Trenton sold $25K | +0.2% (+0.8% vs SPY) | −4.4% (−3.1% vs SPY) | −14.5% (−10.4% vs SPY) |
| Mar 2, 2026 | Earnings | Earnings: missed the EPS estimate by -59.7% | +2.4% (+2.4% vs SPY) | −14.9% (−12.9% vs SPY) | −29.0% (−21.1% vs SPY) |
| Dec 16, 2025 | 8-K | Material definitive agreement | +1.8% (+2.9% vs SPY) | +0.1% (−1.5% vs SPY) | +2.4% (+0.3% vs SPY) |
| Nov 12, 2025 | 8-K | Directors and officers: departures, appointments, pay | −3.5% (−1.9% vs SPY) | −1.0% (+2.1% vs SPY) | −1.5% (−1.2% vs SPY) |
| Nov 10, 2025 | Earnings | Earnings: missed the EPS estimate by -19.0% | −29.3% (−30.9% vs SPY) | −34.2% (−34.3% vs SPY) | −21.1% (−22.9% vs SPY) |
Insiders’ record here
In the year on the chart, Surgery Partners' insiders reported 1 open-market buy ($144K) and 11 sales ($1.3M). Of the 11 old enough to score, 6 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −7.1%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
| 2.01 Completed acquisition or disposition | 2,671 | +0.1% | 52% | +1.2% | ±1.6% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Surgery Partners: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.